London, United Kingdom, July 10, 2018
The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy. The congress, which took place in Paris, France, is the progeny of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and represents a world-leading course in interventional cardiovascular medicine.
More Comprehensive than Ever
The extensive coverage of this event in EMJ Interventional Cardiology 6.1 represents a new direction for this therapeutic series, dedicating even more attention to the uniquely brilliant EuroPCR meeting. As always, the eJournal contains news of the key breakthroughs from the event, such as results from the ORBITA, SYNTAX III, and SPYRAL HTN-ON MED trials, with the latter showing promising developments in renal denervation for the treatment of hypertension. Interviews with the Editorial Board reveal the inner voice of key opinion leaders, and a broad selection of abstract summaries, penned by the authors themselves, offers a snapshot of the plethora of research available at the event. Topics here include results from the latest stents, percutaneous coronary intervention guided by fractional flow reserve, and transcatheter aortic valve implantation in extremely low coronary arteries, to name but a few.
Novel Content
Alongside the more traditional array of content, EMJ Interventional Cardiology 6.1 features a carefully crafted selection of additional topics, designed to create the most well-rounded impression of this expansive event. This includes an expanded Congress Awards section, celebrating, among others, the winners of the prestigious Ethica Award; a History section, wherein the rapid advancement of the interventional discipline is relayed in detail; and a Reporter’s Diary, cataloguing a first-timer’s experience at EuroPCR, complete with useful tips to help delegates get the most from their congress visits in the future.
Inspiring New Direction
EuroPCR 2018 was a whirlwind of learning and excitement for all attendees, and the team at the European Medical Journal have captured the congress’s innovative spirit within the eJournal’s pages. “The production of this eJournal, with its extended congress coverage, has been a labour of love,” said Spencer Gore, CEO of the European Medical Group. “We hope that reading the journal recalls memories of Paris and instils in you the passion, so prominent at EuroPCR, to continue to strive for academic excellence.”
Notes to Editors
About EMJ
The European Medical Journal, is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes and advancements in medicine. Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.
If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].
